FDA Issues 21 New Product-Specific Draft Guidances for Generics, 16 Revised

Drug Industry Daily
A A
The FDA published 21 new and 16 revised product-specific draft guidances, outlining methods for establishing bioequivalence for generics.

To View This Article:

Login

Subscribe To Drug Industry Daily